Exercise and Lumbopelvic Mobility in Pregnancy
Effectiveness of a Six-Week Progressive Resistance Exercise Program on Lumbopelvic Range of Motion in Second-Trimester Pregnancy: A Randomized Controlled Trial
1 other identifier
interventional
50
1 country
1
Brief Summary
Introduction. Pregnancy-induced biomechanical alterations frequently precipitate lumbopelvic mobility restrictions, contributing to musculoskeletal dysfunction and compromised maternal quality of life. This investigation evaluated whether a structured therapeutic exercise rehabilitation protocol could counteract gestational mobility decline and enhance lumbopelvic range of motion in second-trimester pregnant women through targeted neuromuscular conditioning. Methods. A randomized controlled trial enrolled 50 pregnant women (gestational age mean±standard deviation (range): 22±5 (14 -31) weeks) allocated to experimental (n=25) or control (n=25) groups. The experimental group completed a six-week progressive resistance exercise rehabilitation program (36 supervised sessions) targeting lumbopelvic stabilizers, paraspinal musculature, and hip girdle complexes. Primary outcomes comprised eight goniometrically assessed range of motion parameters across sagittal (ie.; lumbar flexion and extension), frontal (ie.; lumbar right and left lateral flexion), and transverse (ie.; right and left axial rotation) anatomical planes, anterior and posterior pelvic tilt. Secondary outcomes comprised back and pelvic pain. All outcomes were measured at baseline, midintervention (week 3), and postintervention (week 6). Percentage changes between postintervention and baseline were calculated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 20, 2025
CompletedFirst Submitted
Initial submission to the registry
February 21, 2026
CompletedFirst Posted
Study publicly available on registry
March 3, 2026
CompletedMarch 3, 2026
February 1, 2026
2 months
February 21, 2026
February 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Lumbopelvic range of motion
Lumbopelvic range of motion constituted eight discrete movement parameters across three anatomical planes consistent with standardized normative values * Lumbar spine sagittal plane flexion (0 to 80 degrees normative range) * Lumbar spine sagittal plane extension (0 to 30 degrees), * Lumbar spine frontal plane lateral flexion to right and left (0 to 40 degrees bilaterally), * Lumbar spine transverse plane axial rotation to right and left (0 to 45 degrees bilaterally) * Anterior pelvic tilt in sagittal plane (13±4.9 degrees population mean), and * Posterior pelvic tilt in sagittal plane (8.9±4.5 degrees population mean)
All outcomes were measured at baseline, midintervention (week 3), and postintervention (week 6)
Back and pelvic pain changes
The endpoint criterion required attainment of end-range position where participants reported substantial stretch sensation without pain (numerical rating scale intensity 4 to 5 of 10) (Hatano et al., 2022)maintained for two seconds
Back and pelvic pain were measured at baseline, midintervention (week 3), and postintervention (week 6)
Study Arms (2)
Resistance training
EXPERIMENTALparticipated in a six-week progressive resistance exercise program
Control group
PLACEBO COMPARATORreceived standard prenatal care without structured exercise prescription, engaging only in routine daily activities
Interventions
We hypothesized that the progressive resistance exercise intervention would generate substantial improvements in all measured lumbopelvic mobility parameters, while control participants would exhibit progressive restrictions as pregnancy advanced, resulting in large between-group differences favoring the intervention group at postintervention assessment. The secondary aim was to compare back and pelvic pain between the two groups.
The control group received standard prenatal care without structured exercise prescription, engaging only in routine daily activities. Control group received counseling to maintain habitual activity patterns without intentional modification, avoiding initiation of new exercise programs during the study period
Eligibility Criteria
You may qualify if:
- specified singleton intrauterine pregnancies confirmed ultrasonographically
- gestational age between 14 and 28 weeks calculated from last menstrual period and corroborated by first-trimester ultrasound biometry
- absence of diagnosed musculoskeletal pathology requiring medical intervention
- medical clearance for moderate-intensity aerobic and resistance exercise from attending obstetricians
- capacity to commit to supervised exercise sessions six days weekly for six consecutive weeks
You may not qualify if:
- encompassed high-risk pregnancy classifications including placenta previa
- pregnancy-induced arterial hypertension or preeclampsia (systolic blood pressure ≥140 mmHg or diastolic ≥90 mmHg with proteinuria
- gestational diabetes mellitus requiring insulin therapy
- multiple gestation
- incompetent cervix or cerclage placement
- persistent second-trimester vaginal bleeding
- premature rupture of membranes
- history of preterm labor
- intrauterine growth restriction below tenth percentile
- contraindications to exercise per American College of Obstetricians and Gynecologists guidelines
- concurrent participation in structured exercise programs exceeding 60 minutes weekly
- acute lumbopelvic pain intensity exceeding six on numerical rating scale (0 to 10) necessitating pharmacological management
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Habil Hamdounilead
- Faculty of Medicine, Soussecollaborator
Study Sites (1)
Institut Supérieur du Sport et de l'Education Physique de Ksar-Saïd
Aryanah, Ariana Governorate, 2073, Tunisia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Assessors conducting goniometric measurements maintained blinding to group allocation through sequential participant coding and spatial separation of assessment and intervention facilities
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
February 21, 2026
First Posted
March 3, 2026
Study Start
September 15, 2024
Primary Completion
October 31, 2024
Study Completion
January 20, 2025
Last Updated
March 3, 2026
Record last verified: 2026-02